Isobel J Fetter

6PUBLICATIONS
82CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 08, 2024
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors.

Ryan B Corcoran, Khanh T Do, Jeong E Kim

|Jan 26, 2023
Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial.

Jun Tian, Jonathan H Chen, Sherry X Chao

|Nov 09, 2022
Identification of a minority population of LMO2+ breast cancer cells that integrate into the vasculature and initiate metastasis.

Shaheen S Sikandar, Gunsagar S Gulati, Jane Antony

|Jul 31, 2021
Results and Molecular Correlates from a Pilot Study of Neoadjuvant Induction FOLFIRINOX Followed by Chemoradiation and Surgery for Gastroesophageal Adenocarcinomas.

Jennifer Y Wo, Jeffrey W Clark, Christine E Eyler

|Apr 30, 2021
FGFR2 Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in Cholangiocarcinoma.

James M Cleary, Srivatsan Raghavan, Qibiao Wu

|Apr 30, 2021
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer.

Aparna R Parikh, Emily E Van Seventer, Giulia Siravegna

Pageof 1

Frequent Collaborators

4 joint publications

Jeffrey W Clark

3 joint publications

Samuel J Klempner

2 joint publications

Eric Roeland

2 joint publications

Geoffrey I Shapiro